In March 2020, as the COVID-19 pandemic took hold, federal guidance permitted greater access to methadone "take-home doses" for people in treatment for opioid use disorder. This paper reviews the treatment experiences of patients and providers at an opioid treatment program in San Francisco.

Sobering centers offer a cost-effective alternative for providing care to people with acute intoxication whose public alcohol or drug use puts themselves or others at risk. New interest in the decades-old approach has been sparked by recent CalAIM (California Advancing and Innovating Medi-Cal). Learn more about these programs through these two publications: a high-level issue brief and a detailed report.

Despite data showing the success of medication-assisted treatment (MAT) in treating drug addiction, objections are still common. This issue brief includes frequent objections and evidence-based responses.

Expanding access to medication-assisted treatment (MAT) in hospitals is critical, given how often patients have a secondary diagnosis of opioid use disorder. This paper describes how MAT is reimbursed in acute inpatient settings and addresses three areas for payment.

The emergency department is an ideal setting to begin medication-assisted treatment. This paper provides answers to frequently asked questions about MAT, focusing on funding and payment options.